HMGB3 promotes the malignant phenotypes and stemness of epithelial ovarian cancer through the MAPK/ERK signaling pathway
Hanlin Ma(Qilu Hospital of Shandong University), Beihua Kong(Qilu Hospital of Shandong University)
Cited by 24
Related Papers
Thio-glucose bound gold nanoparticles enhance radio-cytotoxic targeting of ovarian cancer
|Nanotechnology|2011|176
PBK, targeted by EVI1, promotes metastasis and confers cisplatin resistance through inducing autophagy in high-grade serous ovarian carcinoma
|Cell Death and Disease|2019|74
HMBOX1 interacts with MT2A to regulate autophagy and apoptosis in vascular endothelial cells
|Scientific Reports|2015|67
Niraparib exhibits a synergistic anti-tumor effect with PD-L1 blockade by inducing an immune response in ovarian cancer
|Journal of Translational Medicine|2021|60
HMGB3 promotes PARP inhibitor resistance through interacting with PARP1 in ovarian cancer
|Cell Death and Disease|2022|48